Close Menu

NEW YORK – Thermo Fisher Scientific said on Wednesday that it has a signed a companion diagnostic agreement with Chugai Pharmaceutical, a member of the Roche group.

In addition, Thermo Fisher has applied to the Ministry of Health, Labor, and Welfare of Japan to expand the use of the Oncomine Dx Target test in that country.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.